Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 81 entries
Sorted by: Best Match Show Resources per page
Smoking and renal function in people living with human immunodeficiency virus: a Danish nationwide cohort study.

Clinical epidemiology

Ahlström MG, Feldt-Rasmussen B, Legarth R, Kronborg G, Pedersen C, Larsen CS, Gerstoft J, Obel N.
PMID: 26357490
Clin Epidemiol. 2015 Aug 28;7:391-9. doi: 10.2147/CLEP.S83530. eCollection 2015.

INTRODUCTION: Smoking is a main risk factor for morbidity and mortality in people living with human immunodeficiency virus (PLHIV), but its potential association with renal impairment remains to be established.METHODS: We did a nationwide population-based cohort study in Danish...

Cite
Ahlström MG, Feldt-Rasmussen B, Legarth R, et al. Smoking and renal function in people living with human immunodeficiency virus: a Danish nationwide cohort study. Clin Epidemiol. 2015;7:391-9doi: 10.2147/CLEP.S83530.
Ahlström, M. G., Feldt-Rasmussen, B., Legarth, R., Kronborg, G., Pedersen, C., Larsen, C. S., Gerstoft, J., & Obel, N. (2015). Smoking and renal function in people living with human immunodeficiency virus: a Danish nationwide cohort study. Clinical epidemiology, 7391-9. https://doi.org/10.2147/CLEP.S83530
Ahlström, Magnus Glindvad, et al. "Smoking and renal function in people living with human immunodeficiency virus: a Danish nationwide cohort study." Clinical epidemiology vol. 7 (2015): 391-9. doi: https://doi.org/10.2147/CLEP.S83530
Ahlström MG, Feldt-Rasmussen B, Legarth R, Kronborg G, Pedersen C, Larsen CS, Gerstoft J, Obel N. Smoking and renal function in people living with human immunodeficiency virus: a Danish nationwide cohort study. Clin Epidemiol. 2015 Aug 28;7:391-9. doi: 10.2147/CLEP.S83530. eCollection 2015. PMID: 26357490; PMCID: PMC4559253.
Copy Download .nbib Format: NLM
Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?.

European thyroid journal

Watt T, Hegedüs L, Bjorner JB, Groenvold M, Bonnema SJ, Rasmussen AK, Feldt-Rasmussen U.
PMID: 24783018
Eur Thyroid J. 2012 Oct;1(3):186-92. doi: 10.1159/000342623. Epub 2012 Sep 29.

PURPOSE: To evaluate the relationship between thyroid variables and health-related quality of life (QoL) in patients with autoimmune hypothyroidism, using the thyroid-specific QoL questionnaire ThyPRO.METHODS: In a cross-sectional study, responses to the ThyPRO from 199 outpatients with autoimmune hypothyroidism...

Cite
Watt T, Hegedüs L, Bjorner JB, et al. Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?. Eur Thyroid J. 2012;1(3):186-92doi: 10.1159/000342623.
Watt, T., Hegedüs, L., Bjorner, J. B., Groenvold, M., Bonnema, S. J., Rasmussen, A. K., & Feldt-Rasmussen, U. (2012). Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?. European thyroid journal, 1(3), 186-92. https://doi.org/10.1159/000342623
Watt, Torquil, et al. "Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?." European thyroid journal vol. 1,3 (2012): 186-92. doi: https://doi.org/10.1159/000342623
Watt T, Hegedüs L, Bjorner JB, Groenvold M, Bonnema SJ, Rasmussen AK, Feldt-Rasmussen U. Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?. Eur Thyroid J. 2012 Oct;1(3):186-92. doi: 10.1159/000342623. Epub 2012 Sep 29. PMID: 24783018; PMCID: PMC3821477.
Copy Download .nbib Format: NLM
[Medical co-treatment af acromegaly with a somatostatin analogue and a growth hormone receptor antagonist].

Ugeskrift for laeger

Jørgensen JO, Feldt-Rasmussen U, Frystyk J, Chen JW, Kristensen LØ, Hagen C, Ørskov H.
PMID: 17359735
Ugeskr Laeger. 2007 Mar 05;169(10):911-3.

We tested the effect of co-treatment of acromegaly with a somatostatin analogue (SA) and a growth hormone receptor antagonist (GHA). Eleven patients underwent: 1) conventional treatment with SA, 2) discontinued treatment, 3) 6 weeks treatment with GHA (10 mg),...

Cite
Jørgensen JO, Feldt-Rasmussen U, Frystyk J, et al. Medicinsk kombinationsbehandling af akromegali med somatostatinanalog og en vaeksthormon-receptorantagonist. [Medical co-treatment af acromegaly with a somatostatin analogue and a growth hormone receptor antagonist]. Ugeskr Laeger. 2007;169(10):911-3
Jørgensen, J. O., Feldt-Rasmussen, U., Frystyk, J., Chen, J. W., Kristensen, L. �. �., Hagen, C., & Ørskov, H. (2007). Medicinsk kombinationsbehandling af akromegali med somatostatinanalog og en vaeksthormon-receptorantagonist. [Medical co-treatment af acromegaly with a somatostatin analogue and a growth hormone receptor antagonist]. Ugeskrift for laeger, 169(10), 911-3.
Jørgensen, Jens Otto Lunde, et al. "Medicinsk kombinationsbehandling af akromegali med somatostatinanalog og en vaeksthormon-receptorantagonist." [Medical co-treatment af acromegaly with a somatostatin analogue and a growth hormone receptor antagonist]. Ugeskrift for laeger vol. 169,10 (2007): 911-3.
Jørgensen JO, Feldt-Rasmussen U, Frystyk J, Chen JW, Kristensen LØ, Hagen C, Ørskov H. Medicinsk kombinationsbehandling af akromegali med somatostatinanalog og en vaeksthormon-receptorantagonist. [Medical co-treatment af acromegaly with a somatostatin analogue and a growth hormone receptor antagonist]. Ugeskr Laeger. 2007 Mar 05;169(10):911-3. Danish. PMID: 17359735.
Copy Download .nbib Format: NLM
Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?.

Nutrition & metabolism

Belsing TZ, Tofteng C, Langdahl BL, Charles P, Feldt-Rasmussen U.
PMID: 20807449
Nutr Metab (Lond). 2010 Sep 01;7:72. doi: 10.1186/1743-7075-7-72.

CONTEXT: Hyperthyroidism can lead to reduced bone mineral density (BMD) and increased fracture risk particularly in postmenopausal women, but the mechanism behind is still unclear.OBJECTIVE: Prospective examination of the influence of thyroid hormones and/or thyroid autoantibodies on BMD in...

Cite
Belsing TZ, Tofteng C, Langdahl BL, et al. Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?. Nutr Metab (Lond). 2010;7:72doi: 10.1186/1743-7075-7-72.
Belsing, T. Z., Tofteng, C., Langdahl, B. L., Charles, P., & Feldt-Rasmussen, U. (2010). Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?. Nutrition & metabolism, 772. https://doi.org/10.1186/1743-7075-7-72
Belsing, Tina Z, et al. "Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?." Nutrition & metabolism vol. 7 (2010): 72. doi: https://doi.org/10.1186/1743-7075-7-72
Belsing TZ, Tofteng C, Langdahl BL, Charles P, Feldt-Rasmussen U. Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?. Nutr Metab (Lond). 2010 Sep 01;7:72. doi: 10.1186/1743-7075-7-72. PMID: 20807449; PMCID: PMC2936437.
Copy Download .nbib Format: NLM
Cytokines in autoimmunity.

Immunology today

Bendtzen K, Rasmussen AK, Bech K, Feldt-Rasmussen U, Egeberg J.
PMID: 25290426
Immunol Today. 1987;8(7):204. doi: 10.1016/0167-5699(87)90163-0.

No abstract available.

Cite
Bendtzen K, Rasmussen AK, Bech K, et al. Cytokines in autoimmunity. Immunol Today. 1987;8(7):204doi: 10.1016/0167-5699(87)90163-0.
Bendtzen, K., Rasmussen, A. K., Bech, K., Feldt-Rasmussen, U., & Egeberg, J. (1987). Cytokines in autoimmunity. Immunology today, 8(7), 204. https://doi.org/10.1016/0167-5699(87)90163-0
Bendtzen, K, et al. "Cytokines in autoimmunity." Immunology today vol. 8,7 (1987): 204. doi: https://doi.org/10.1016/0167-5699(87)90163-0
Bendtzen K, Rasmussen AK, Bech K, Feldt-Rasmussen U, Egeberg J. Cytokines in autoimmunity. Immunol Today. 1987;8(7):204. doi: 10.1016/0167-5699(87)90163-0. PMID: 25290426.
Copy Download .nbib Format: NLM
Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease.

Thyroid research

Ercolano MA, Drnovsek ML, Silva Croome MC, Moos M, Fuentes AM, Viale F, Feldt-Rasmussen U, Gauna AT.
PMID: 24020400
Thyroid Res. 2013 Sep 11;6(1):11. doi: 10.1186/1756-6614-6-11.

BACKGROUND: Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves' disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabolism. Thyrotropin (TSH) is known to affect directly the bone...

Cite
Ercolano MA, Drnovsek ML, Silva Croome MC, et al. Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease. Thyroid Res. 2013;6(1):11doi: 10.1186/1756-6614-6-11.
Ercolano, M. A., Drnovsek, M. L., Silva Croome, M. C., Moos, M., Fuentes, A. M., Viale, F., Feldt-Rasmussen, U., & Gauna, A. T. (2013). Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease. Thyroid research, 6(1), 11. https://doi.org/10.1186/1756-6614-6-11
Ercolano, Monica A, et al. "Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease." Thyroid research vol. 6,1 (2013): 11. doi: https://doi.org/10.1186/1756-6614-6-11
Ercolano MA, Drnovsek ML, Silva Croome MC, Moos M, Fuentes AM, Viale F, Feldt-Rasmussen U, Gauna AT. Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease. Thyroid Res. 2013 Sep 11;6(1):11. doi: 10.1186/1756-6614-6-11. PMID: 24020400; PMCID: PMC3847206.
Copy Download .nbib Format: NLM
Subclinical hypothyroidism in pregnancy: to treat or not to treat.

Endocrine

Feldt-Rasmussen U.
PMID: 24122120
Endocrine. 2013 Oct 10; doi: 10.1007/s12020-013-0045-5. Epub 2013 Oct 10.

No abstract available.

Cite
Feldt-Rasmussen U. Subclinical hypothyroidism in pregnancy: to treat or not to treat. Endocrine. 2013;doi: 10.1007/s12020-013-0045-5.
Feldt-Rasmussen, U. (2013). Subclinical hypothyroidism in pregnancy: to treat or not to treat. Endocrine, . https://doi.org/10.1007/s12020-013-0045-5
Feldt-Rasmussen, Ulla. "Subclinical hypothyroidism in pregnancy: to treat or not to treat." Endocrine vol. (2013). doi: https://doi.org/10.1007/s12020-013-0045-5
Feldt-Rasmussen U. Subclinical hypothyroidism in pregnancy: to treat or not to treat. Endocrine. 2013 Oct 10; doi: 10.1007/s12020-013-0045-5. Epub 2013 Oct 10. PMID: 24122120.
Copy Download .nbib Format: NLM
Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study.

Endocrine connections

Mathiesen JS, Kroustrup JP, Vestergaard P, Poulsen PL, Rasmussen ÅK, Feldt-Rasmussen U, Schytte S, Londero SC, Pedersen HB, Hahn CH, Bentzen J, Möller S, Gaustadnes M, Rossing M, Nielsen FC, Brixen K, Godballe C.
PMID: 30550378
Endocr Connect. 2019 Jan 01;8(1):1-7. doi: 10.1530/EC-18-0494.

A recent study proposed new TNM groupings for better survival discrimination among stage groups for medullary thyroid carcinoma (MTC) and validated these groupings in a population-based cohort in the United States. However, it is unknown how well the groupings...

Cite
Mathiesen JS, Kroustrup JP, Vestergaard P, et al. Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study. Endocr Connect. 2019;8(1):1-7doi: 10.1530/EC-18-0494.
Mathiesen, J. S., Kroustrup, J. P., Vestergaard, P., Poulsen, P. L., Rasmussen, �. �. K., Feldt-Rasmussen, U., Schytte, S., Londero, S. C., Pedersen, H. B., Hahn, C. H., Bentzen, J., Möller, S., Gaustadnes, M., Rossing, M., Nielsen, F. C., Brixen, K., & Godballe, C. (2019). Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study. Endocrine connections, 8(1), 1-7. https://doi.org/10.1530/EC-18-0494
Mathiesen, Jes Sloth, et al. "Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study." Endocrine connections vol. 8,1 (2019): 1-7. doi: https://doi.org/10.1530/EC-18-0494
Mathiesen JS, Kroustrup JP, Vestergaard P, Poulsen PL, Rasmussen ÅK, Feldt-Rasmussen U, Schytte S, Londero SC, Pedersen HB, Hahn CH, Bentzen J, Möller S, Gaustadnes M, Rossing M, Nielsen FC, Brixen K, Godballe C. Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study. Endocr Connect. 2019 Jan 01;8(1):1-7. doi: 10.1530/EC-18-0494. PMID: 30550378; PMCID: PMC6330714.
Copy Download .nbib Format: NLM
Risk of Thyroid Cancer in 1,504 Patients Referred for Thyroid Surgery with Assumed Benign Histology.

European thyroid journal

Gram SB, Rasmussen JH, Feldt-Rasmussen U, Bentzen J, Lelkaitis G, von Buchwald C, Hahn CH.
PMID: 31768335
Eur Thyroid J. 2019 Oct;8(5):246-255. doi: 10.1159/000500539. Epub 2019 Jun 26.

OBJECTIVES: The aims of this study were to report the risk of thyroid malignancy in cases of either benign fine-needle aspiration (FNA) or without FNA performed, and to investigate possible predictive factors for thyroid malignancy in a population with...

Cite
Gram SB, Rasmussen JH, Feldt-Rasmussen U, et al. Risk of Thyroid Cancer in 1,504 Patients Referred for Thyroid Surgery with Assumed Benign Histology. Eur Thyroid J. 2019;8(5):246-255doi: 10.1159/000500539.
Gram, S. B., Rasmussen, J. H., Feldt-Rasmussen, U., Bentzen, J., Lelkaitis, G., von Buchwald, C., & Hahn, C. H. (2019). Risk of Thyroid Cancer in 1,504 Patients Referred for Thyroid Surgery with Assumed Benign Histology. European thyroid journal, 8(5), 246-255. https://doi.org/10.1159/000500539
Gram, Signe Buhl, et al. "Risk of Thyroid Cancer in 1,504 Patients Referred for Thyroid Surgery with Assumed Benign Histology." European thyroid journal vol. 8,5 (2019): 246-255. doi: https://doi.org/10.1159/000500539
Gram SB, Rasmussen JH, Feldt-Rasmussen U, Bentzen J, Lelkaitis G, von Buchwald C, Hahn CH. Risk of Thyroid Cancer in 1,504 Patients Referred for Thyroid Surgery with Assumed Benign Histology. Eur Thyroid J. 2019 Oct;8(5):246-255. doi: 10.1159/000500539. Epub 2019 Jun 26. PMID: 31768335; PMCID: PMC6873058.
Copy Download .nbib Format: NLM
Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.

Nephron

Bomholt T, Feldt-Rasmussen B, Butt R, Borg R, Sarwary MH, Elung-Jensen T, Almdal T, Knop FK, Nørgaard K, Ranjan AG, Larsson A, Rix M, Hornum M.
PMID: 34731864
Nephron. 2021 Nov 03;1-7. doi: 10.1159/000519493. Epub 2021 Nov 03.

INTRODUCTION: Shortened erythrocyte life span and erythropoietin-stimulating agents may affect hemoglobin A1c (HbA1c) levels in patients receiving peritoneal dialysis (PD). We compared HbA1c with interstitial glucose measured by continuous glucose monitoring (CGM) in patients with type 2 diabetes receiving...

Cite
Bomholt T, Feldt-Rasmussen B, Butt R, et al. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring. Nephron. 2021;1-7doi: 10.1159/000519493.
Bomholt, T., Feldt-Rasmussen, B., Butt, R., Borg, R., Sarwary, M. H., Elung-Jensen, T., Almdal, T., Knop, F. K., Nørgaard, K., Ranjan, A. G., Larsson, A., Rix, M., & Hornum, M. (2021). Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring. Nephron, 1-7. https://doi.org/10.1159/000519493
Bomholt, Tobias, et al. "Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring." Nephron vol. (2021): 1-7. doi: https://doi.org/10.1159/000519493
Bomholt T, Feldt-Rasmussen B, Butt R, Borg R, Sarwary MH, Elung-Jensen T, Almdal T, Knop FK, Nørgaard K, Ranjan AG, Larsson A, Rix M, Hornum M. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring. Nephron. 2021 Nov 03;1-7. doi: 10.1159/000519493. Epub 2021 Nov 03. PMID: 34731864.
Copy Download .nbib Format: NLM
Brain tumours result in sleep disorders in children and adolescents.

Sleep medicine

Pickering L, Main KM, Sehested A, Mathiasen R, Feldt-Rasmussen U, Klose M, Kotagal S, Jennum PJ.
PMID: 34715527
Sleep Med. 2021 Dec;88:13-21. doi: 10.1016/j.sleep.2021.09.016. Epub 2021 Oct 02.

BACKGROUND AND OBJECTIVES: Sleep disturbances are frequently reported in children with brain tumours. The objective of our cross-sectional study was to systematically examine sleep in these children. We hypothesised that children with tumours involving the sleep-wake-regulatory areas have an...

Cite
Pickering L, Main KM, Sehested A, et al. Brain tumours result in sleep disorders in children and adolescents. Sleep Med. 2021;88:13-21doi: 10.1016/j.sleep.2021.09.016.
Pickering, L., Main, K. M., Sehested, A., Mathiasen, R., Feldt-Rasmussen, U., Klose, M., Kotagal, S., & Jennum, P. J. (2021). Brain tumours result in sleep disorders in children and adolescents. Sleep medicine, 8813-21. https://doi.org/10.1016/j.sleep.2021.09.016
Pickering, Line, et al. "Brain tumours result in sleep disorders in children and adolescents." Sleep medicine vol. 88 (2021): 13-21. doi: https://doi.org/10.1016/j.sleep.2021.09.016
Pickering L, Main KM, Sehested A, Mathiasen R, Feldt-Rasmussen U, Klose M, Kotagal S, Jennum PJ. Brain tumours result in sleep disorders in children and adolescents. Sleep Med. 2021 Dec;88:13-21. doi: 10.1016/j.sleep.2021.09.016. Epub 2021 Oct 02. PMID: 34715527.
Copy Download .nbib Format: NLM
Brain tumours result in sleep disorders in children and adolescents.

Sleep medicine

Pickering L, Main KM, Sehested A, Mathiasen R, Feldt-Rasmussen U, Klose M, Kotagal S, Jennum PJ.
PMID: 34715527
Sleep Med. 2021 Dec;88:13-21. doi: 10.1016/j.sleep.2021.09.016. Epub 2021 Oct 02.

BACKGROUND AND OBJECTIVES: Sleep disturbances are frequently reported in children with brain tumours. The objective of our cross-sectional study was to systematically examine sleep in these children. We hypothesised that children with tumours involving the sleep-wake-regulatory areas have an...

Cite
Pickering L, Main KM, Sehested A, et al. Brain tumours result in sleep disorders in children and adolescents. Sleep Med. 2021;88:13-21doi: 10.1016/j.sleep.2021.09.016.
Pickering, L., Main, K. M., Sehested, A., Mathiasen, R., Feldt-Rasmussen, U., Klose, M., Kotagal, S., & Jennum, P. J. (2021). Brain tumours result in sleep disorders in children and adolescents. Sleep medicine, 8813-21. https://doi.org/10.1016/j.sleep.2021.09.016
Pickering, Line, et al. "Brain tumours result in sleep disorders in children and adolescents." Sleep medicine vol. 88 (2021): 13-21. doi: https://doi.org/10.1016/j.sleep.2021.09.016
Pickering L, Main KM, Sehested A, Mathiasen R, Feldt-Rasmussen U, Klose M, Kotagal S, Jennum PJ. Brain tumours result in sleep disorders in children and adolescents. Sleep Med. 2021 Dec;88:13-21. doi: 10.1016/j.sleep.2021.09.016. Epub 2021 Oct 02. PMID: 34715527.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 81 entries